Open AccessOvercoming Acquired Resistance Mutation MET D1228N to Crizotinib With Cabozantinib in NSCLC With MET Exon 14 Skipping Mutation
Author(s) -
Melinda A. Pruis,
Marthe S. Paats,
W. R. R. Geurts,
Hendrikus J. Dubbink,
AnneMarie C. Dingemans
Publication year - 2021
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.21.00076
Subject(s) - cabozantinib , crizotinib , exon , mutation , cancer research , resistance mutation , medicine , acquired resistance , genetics , oncology , biology , lung cancer , cancer , gene , polymerase chain reaction , reverse transcriptase , malignant pleural effusion , vegf receptors
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom